Résultats de recherche
Il y a 1 jour · Usher syndrome is a genetic disorder characterized by hearing loss, vestibular impairment, and visual loss due to retinitis pigmentosa. It is a syndrome rather than a disease because it has multiple causes. In this regard, there are multiple gene's associated with 4 types of Usher syndrome. About half of all cases are from USH2A (Zaw et al, 2022).
Il y a 5 jours · Mutations in these genes can lead to Usher syndrome, ... Wild-type zebrafish strain NHGRI-1 51 and mitfa W2/W2 mutants were raised and maintained at 28.5 °C on a 14 h light/10 h dark cycle.
Il y a 2 jours · Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type II or non-syndromic retinitis pigmentosa. McGee TL Journal of medical genetics 2010 PMID: 20507924: Identification of novel USH2A mutations: implications for the structure of USH2A protein.
Il y a 1 jour · Physicians reported that three main types of genetic testing were used to establish XLRP diagnosis: (1) targeted multigene panels that include a limited number of known disease genes causative of a specific category of IRDs, such as Leber congenital amaurosis, XLRP, Usher syndrome, and Stargardt disease; (2) next-generation sequencing (NGS) panels inclusive of many different known disease ...
Il y a 5 jours · Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients. American Journal of Human Genetics, 59 (5), 1074-1083. Kimberling, W. J. & Möller, C. (1995).
Il y a 1 jour · There's only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available. With a new ...
Il y a 1 jour · Credit: Case Western Reserve University. CLEVELAND—There’s only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available. With a new three-year, $1.5 million grant from the Foundation Fighting Blindness, Shigemi Matsuyama, an ...
